Preventable Differences in Recommended Outpatient COVID-19 Treatment Among Adults With COVID-19 in the United States

Thomas Carton, PhD, MS, Chief Data and Strategy Officer at the Louisiana Public Health Institute (LPHI), is a researcher on this article, published in Medical Care. The study uses PCORnet® data to describe outpatient antiviral prescribing patterns and highlights differences in treatment across patient groups that may be preventable.

Preventable Differences in Recommended Outpatient COVID-19 Treatment Among Adults With COVID-19 in the United States

Previous
Previous

The CHI-RON Study: Using PCORnet® and Patient Engagement Strategies to Improve Diversity Among Research Participants in the Congenital Heart Initiative

Next
Next

PCORnet®: 10 Years of Research Innovation